Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland Publisert: 07.09.2021 Navamedic ASA: Q2 and first half 2021 financial results Publisert: 13.08.2021 Navamedic ASA: Invitation to 2021 Second quarter presentation Publisert: 10.08.2021 Obesity patient support program launched in Norway Publisert: 20.05.2021 Navamedic ASA: Notice of Annual General Meeting Publisert: 12.05.2021 Navamedic ASA: Q1 2021 financial Publisert: 11.05.2021 FørsteForrige910111213NesteSiste
Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland Publisert: 07.09.2021